GRX
Income statement / Annual
Last year (2025), Gabelli Healthcare & WellnessRx Trust's total revenue was $15.28 M,
an increase of 368.67% from the previous year.
In 2025, Gabelli Healthcare & WellnessRx Trust's net income was $2.29 M.
See Gabelli Healthcare & WellnessRx Trust,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
| Operating Revenue |
$15.28 M |
$3.26 M |
$4.01 M |
$15.59 M |
$23.39 M |
$25.01 M |
$53.76 M |
-$1.53 M |
$32.50 M |
| Cost of Revenue |
$2.48 M
|
$2.92 M
|
$2.77 M
|
$3.41 M
|
$3.46 M
|
$3.07 M
|
$3.29 M
|
$3.40 M
|
$3.36 M
|
| Gross Profit |
$12.79 M
|
$342.91 K
|
$1.24 M
|
$12.18 M
|
$19.93 M
|
$21.93 M
|
$50.47 M
|
-$4.93 M
|
$0.00
|
| Gross Profit Ratio |
0.84
|
0.11
|
0.31
|
0.78
|
0.85
|
0.88
|
0.94
|
3.22
|
0
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$0.00
|
$420.15 K
|
$542.64 K
|
$730.22 K
|
$753.55 K
|
$825.28 K
|
$602.51 K
|
$750.29 K
|
$815.04 K
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$0.00
|
$420.15 K
|
$542.64 K
|
$730.22 K
|
$753.55 K
|
$825.28 K
|
$602.51 K
|
$750.29 K
|
$815.04 K
|
| Other Expenses |
$8.05 M
|
$207.76 K
|
$274.64 K
|
-$2.33 K
|
-$2.28 K
|
$24.18 M
|
-$1.86 K
|
-$2.10 K
|
-$2.17 K
|
| Operating Expenses |
$8.05 M
|
$627.91 K
|
$817.28 K
|
$727.90 K
|
$751.27 K
|
$25.01 M
|
$600.65 K
|
$748.19 K
|
$812.87 K
|
| Cost And Expenses |
$10.53 M
|
$3.54 M
|
$3.59 M
|
$59.83 M
|
-$21.30 M
|
$25.01 M
|
$600.65 K
|
$748.19 K
|
$812.87 K
|
| Interest Income |
$3.70 M
|
$380.97 K
|
$636.61 K
|
$462.18 K
|
$6.73 K
|
$66.49 K
|
$314.51 K
|
$350.76 K
|
$152.43 K
|
| Interest Expense |
$2.47 M
|
$2.92 M
|
$2.77 M
|
$3.18 M
|
$1.94 M
|
$57.78 K
|
$0.00
|
$117.00
|
$94.00
|
| Depreciation & Amortization |
$0.00
|
$0.00
|
$0.00
|
$228.49 K
|
$236.56 K
|
$0.00
|
$171.86 K
|
$0.00
|
$52.52 K
|
| EBITDA |
$4.77 M |
$2.68 M |
$3.20 M |
-$44.26 M |
$44.93 M |
$24.33 M |
$53.16 M |
-$2.28 M |
$31.69 M |
| EBITDA Ratio |
0.31
|
0.82
|
0.8
|
-2.84
|
1.92
|
0.97
|
0.99
|
1.49
|
0.97
|
| Operating Income Ratio |
0.31
|
0.82
|
0.8
|
-2.84
|
1.91
|
0.97
|
0.99
|
1.49
|
0.97
|
| Total Other Income/Expenses Net |
-$2.45 M
|
-$2.97 M
|
-$2.78 M
|
-$3.21 M
|
-$1.95 M
|
-$145.38 K
|
$0.00
|
-$117.00
|
-$94.00
|
| Income Before Tax |
$2.29 M
|
-$285.00 K
|
$422.80 K
|
-$47.44 M
|
$42.74 M
|
$24.18 M
|
$53.16 M
|
-$2.28 M
|
$31.69 M
|
| Income Before Tax Ratio |
0.15
|
-0.09
|
0.11
|
-3.04
|
1.83
|
0.97
|
0.99
|
1.49
|
0.97
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$52.52 K
|
| Net Income |
$2.29 M
|
-$285.00 K
|
$422.80 K
|
-$47.44 M
|
$42.74 M
|
$24.18 M
|
$53.16 M
|
-$2.28 M
|
$31.69 M
|
| Net Income Ratio |
0.15
|
-0.09
|
0.11
|
-3.04
|
1.83
|
0.97
|
0.99
|
1.49
|
0.97
|
| EPS |
0.15 |
-0.0184 |
0.0265 |
-2.78 |
2.48 |
1.23 |
2.68 |
-0.33 |
1.6 |
| EPS Diluted |
0.15 |
-0.0184 |
0.0265 |
-2.78 |
2.48 |
1.23 |
2.68 |
-0.33 |
1.6 |
| Weighted Average Shares Out |
$15.30 M
|
$15.52 M
|
$15.96 M
|
$17.04 M
|
$17.23 M
|
$17.53 M
|
$18.38 M
|
$18.68 M
|
$17.37 M
|
| Weighted Average Shares Out Diluted |
$15.30 M
|
$15.52 M
|
$15.96 M
|
$17.04 M
|
$17.23 M
|
$17.53 M
|
$18.38 M
|
$18.68 M
|
$17.37 M
|
| Link |
|
|
|
|
|
|
|
|
|
